LEAPER Trademark

Trademark Overview


On Saturday, May 7, 2022, a trademark application was filed for LEAPER with the United States Patent and Trademark Office. The USPTO has given the LEAPER trademark a serial number of 79346215. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by EDIGENE INC.. The LEAPER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, medicated dermatological preparations and substances, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use

Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics
leaper

General Information


Serial Number79346215
Word MarkLEAPER
Filing DateSaturday, May 7, 2022
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064525
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesCells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, medicated dermatological preparations and substances, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use
Goods and ServicesMedical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEDIGENE INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameEDIGENE INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameEDIGENE INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Sunday, August 6, 2023NOTIFICATION PROCESSED BY IB
Thursday, July 20, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 20, 2023FINAL DISPOSITION PROCESSED
Thursday, June 29, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2023NOTICE OF PUBLICATION
Friday, February 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 2, 2023ASSIGNED TO EXAMINER
Tuesday, August 2, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB